Grammati Sarri

1.2k total citations
39 papers, 743 citations indexed

About

Grammati Sarri is a scholar working on Economics and Econometrics, General Health Professions and Hematology. According to data from OpenAlex, Grammati Sarri has authored 39 papers receiving a total of 743 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Economics and Econometrics, 9 papers in General Health Professions and 6 papers in Hematology. Recurrent topics in Grammati Sarri's work include Health Systems, Economic Evaluations, Quality of Life (18 papers), Healthcare cost, quality, practices (6 papers) and Pharmaceutical Economics and Policy (6 papers). Grammati Sarri is often cited by papers focused on Health Systems, Economic Evaluations, Quality of Life (18 papers), Healthcare cost, quality, practices (6 papers) and Pharmaceutical Economics and Policy (6 papers). Grammati Sarri collaborates with scholars based in United States, United Kingdom and Japan. Grammati Sarri's co-authors include Melanie Davies, Mary Ann Lumsden, Vanessa Delgado Nunes, Sofia Dias, Hugo Pedder, Robert Kirschen, Parmjit Singh, Edna Keeney, James P Neilson and J. Helen Cross and has published in prestigious journals such as Journal of Clinical Oncology, CHEST Journal and BMJ.

In The Last Decade

Grammati Sarri

34 papers receiving 720 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Grammati Sarri United States 14 138 110 102 102 78 39 743
Khaled Alswat Saudi Arabia 15 201 1.5× 54 0.5× 45 0.4× 55 0.5× 67 0.9× 45 953
Holly L. Thacker United States 14 151 1.1× 121 1.1× 32 0.3× 22 0.2× 72 0.9× 55 579
Cristiane R Macedo Brazil 17 38 0.3× 26 0.2× 22 0.2× 110 1.1× 32 0.4× 34 947
Oumin Shi China 17 84 0.6× 34 0.3× 15 0.1× 58 0.6× 65 0.8× 32 1.3k
Gayatri Ranganathan United States 14 46 0.3× 34 0.3× 79 0.8× 30 0.3× 17 0.2× 30 821
Yeoun Joo Lee South Korea 18 127 0.9× 259 2.4× 60 0.6× 147 1.4× 63 0.8× 83 1.3k
Jung Su Lee Japan 13 259 1.9× 107 1.0× 16 0.2× 34 0.3× 78 1.0× 37 725
Emmanuelle Noirrit‐Esclassan France 13 46 0.3× 119 1.1× 11 0.1× 22 0.2× 29 0.4× 32 611
Peter F. Schnatz United States 22 146 1.1× 94 0.9× 59 0.6× 59 0.6× 202 2.6× 80 1.3k
Mitsunori Murata Japan 17 155 1.1× 102 0.9× 31 0.3× 174 1.7× 53 0.7× 43 934

Countries citing papers authored by Grammati Sarri

Since Specialization
Citations

This map shows the geographic impact of Grammati Sarri's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Grammati Sarri with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Grammati Sarri more than expected).

Fields of papers citing papers by Grammati Sarri

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Grammati Sarri. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Grammati Sarri. The network helps show where Grammati Sarri may publish in the future.

Co-authorship network of co-authors of Grammati Sarri

This figure shows the co-authorship network connecting the top 25 collaborators of Grammati Sarri. A scholar is included among the top collaborators of Grammati Sarri based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Grammati Sarri. Grammati Sarri is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Abògúnr̀in, Ṣẹ̀yẹ, Jeffrey M. Muir, Cristiano A. F. Zerbini, & Grammati Sarri. (2025). How much can we save by applying artificial intelligence in evidence synthesis? Results from a pragmatic review to quantify workload efficiencies and cost savings. Frontiers in Pharmacology. 16. 1454245–1454245. 1 indexed citations
2.
Stillman, Ipek Özer, et al.. (2025). Rooting patient-reported outcomes in clinical care: a scoping review on benefits, challenges, and opportunities for patients and clinicians. Health and Quality of Life Outcomes. 23(1). 93–93.
3.
Sarri, Grammati, et al.. (2024). Navigating the unknown: how to best ‘reflect’ standard of care in indications without a dedicated treatment pathway in health technology assessment submissions. Journal of Comparative Effectiveness Research. 13(2). e230145–e230145. 1 indexed citations
4.
5.
Sarri, Grammati & Luis Hernández. (2024). The maze of real-world evidence frameworks: from a desert to a jungle! An environmental scan and comparison across regulatory and health technology assessment agencies. Journal of Comparative Effectiveness Research. 13(9). e240061–e240061. 4 indexed citations
6.
Muir, Jeffrey M., Amruta Radhakrishnan, Andreas Freitag, Ipek Özer Stillman, & Grammati Sarri. (2023). Reconstructing the value puzzle in health technology assessment: a pragmatic review to determine which modelling methods can account for additional value elements. Frontiers in Pharmacology. 14. 1197259–1197259. 4 indexed citations
7.
Sarri, Grammati, Anna Forsythe, Jamie Elvidge, & Dalia Dawoud. (2023). Living health technology assessments: how close to living reality?. BMJ evidence-based medicine. 28(6). 369–371. 5 indexed citations
8.
9.
Sarri, Grammati. (2022). Can Real-World Evidence Help Restore Decades of Health Inequalities by Informing Health Care Decision-Making? Certainly, and Here is How. Frontiers in Pharmacology. 13. 905820–905820. 4 indexed citations
10.
Kongnakorn, Thitima, Grammati Sarri, Andreas Freitag, et al.. (2021). Modeling Challenges in Cost-Effectiveness Analysis of First-Line Immuno-Oncology Therapies in Non-small Cell Lung Cancer: A Systematic Literature Review. PharmacoEconomics. 40(2). 183–201. 5 indexed citations
11.
12.
Lee, Soyon, et al.. (2020). <p>Patient-Reported Outcomes and Economic Burden of Adults with Sickle Cell Disease in the United States: A Systematic Review</p>. International Journal of General Medicine. Volume 13. 361–377. 26 indexed citations
13.
Sarri, Grammati, Elisabetta Patorno, Hongbo Yuan, et al.. (2020). Framework for the synthesis of non-randomised studies and randomised controlled trials: a guidance on conducting a systematic review and meta-analysis for healthcare decision making. BMJ evidence-based medicine. 27(2). 109–119. 68 indexed citations
14.
15.
Sarri, Grammati, et al.. (2019). PND93 WHAT GOOD ARE DIGITAL TECHNOLOGIES IN ALZHEIMER'S DISEASE RESEARCH? - A SYSTEMATIC LITERATURE REVIEW. Value in Health. 22. S754–S754. 1 indexed citations
16.
17.
Sarri, Grammati, Hugo Pedder, Sofia Dias, Yu Guo, & Mary Ann Lumsden. (2017). Vasomotor Symptoms Resulting From Natural Menopause: A Systematic Review and Network Meta-analysis of Treatment Effects From the National Institute for Health and Care Excellence Guideline on Menopause. Obstetrical & Gynecological Survey. 72(12). 719–720. 3 indexed citations
18.
Pedder, Hugo, Grammati Sarri, Edna Keeney, Vanessa Delgado Nunes, & Sofia Dias. (2016). Data extraction for complex meta-analysis (DECiMAL) guide. Systematic Reviews. 5(1). 212–212. 93 indexed citations
19.
Sarri, Grammati, et al.. (2015). Preterm labour: summary of NICE guidance. BMJ. 351. h6283–h6283. 23 indexed citations
20.
Sarri, Grammati, et al.. (2015). Diagnosis and management of menopause: summary of NICE guidance. BMJ. 351(nov12 10). h5746–h5746. 71 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Khaled Alswat Breakdown of academic impact, for papers by Holly L. Thacker Breakdown of academic impact, for papers by Cristiane R Macedo Breakdown of academic impact, for papers by Oumin Shi Breakdown of academic impact, for papers by Gayatri Ranganathan Breakdown of academic impact, for papers by Yeoun Joo Lee Breakdown of academic impact, for papers by Jung Su Lee Breakdown of academic impact, for papers by Emmanuelle Noirrit‐Esclassan Breakdown of academic impact, for papers by Peter F. Schnatz Breakdown of academic impact, for papers by Mitsunori Murata
Rankless by CCL
2026